The Effect of Thyroid Dysfunction on the Cardiovascular Risk of Type 2 Diabetes Mellitus Patients in Ghana

Journal of Diabetes Research
Osei Sarfo-KantankaIshmael Kyei

Abstract

Thyroid dysfunction is known to exaggerate the coronary heart disease (CHD) risk associated with type 2 diabetes mellitus (T2DM) among whites. The effect is yet to be studied among African populations. This is a cross-sectional study involving 780 T2DM patients enrolled in a diabetes clinic in Kumasi, Ghana. CHD risk was estimated using the Framingham and UKPDS risk scores. Risks were categorised as low (<10%), intermediate (10-19%), and high (≥20%). Associations between metabolic risk factors, thyroid dysfunction, and CHD risk were measured using Spearman's partial correlation analysis while controlling for age and gender. Differences were considered statistically significant at p < 0.05. 780 T2DM patients (57.7% females), mean ± SD age of 57.4 ± 9.4 was analysed. The median (IQR) 10-year CHD score estimated using the Framingham and UKPDS risk engines for males and females was 12 (8-20), 9.4 (5.7-13.4), p < 0.0001 and 3 (1-6), 5.8 (3.4-9.6), p < 0.0001, respectively. Positive correlation was found between CHD risk and HbA1c, total cholesterol, low-density lipoprotein cholesterol, systolic blood pressure, and thyroid stimulating hormone. The presence of thyroid dysfunction significantly increased the CHD risk associated with T2...Continue Reading

References

May 29, 1998·Circulation·P W WilsonW B Kannel
Apr 12, 2002·Diabetes Research and Clinical Practice·Albert G B AmoahSamuel Adjei
Jan 31, 2003·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Nov 5, 2003·Current Hypertension Reports·Sara Danzi, Irwin Klein
Jul 20, 2005·Treatments in Endocrinology·Emiliano A PalmieriBernadette Biondi
Mar 2, 2006·JAMA : the Journal of the American Medical Association·Anne R CappolaPaul W Ladenson
Jul 25, 2007·Archives of Internal Medicine·Giorgio IervasiAlessandro Pingitore
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
May 21, 2008·Annals of Internal Medicine·Nicolas OchsNicolas Rodondi
May 29, 2008·The Journal of Clinical Endocrinology and Metabolism·Salman RazviSimon H S Pearce
Oct 29, 2009·Diabetology & Metabolic Syndrome·Marilia B GomesSergio A Dib
Jul 14, 2010·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·A A RivelleseO Vaccaro
Dec 7, 2010·Trends in Cardiovascular Medicine·Caroline S Fox
Nov 9, 2011·Nature Reviews. Endocrinology·Lei ChenPaul Z Zimmet
Aug 16, 2014·World Journal of Diabetes·Iciar Martín-TimónFrancisco Javier Del Cañizo-Gómez

❮ Previous
Next ❯

Citations

Aug 23, 2019·Irish Journal of Medical Science·Roxana Maria TudorChristopher J Thompson
Dec 17, 2021·Endocrinology and Metabolism·Eyun SongHye Jin Yoo

❮ Previous
Next ❯

Software Mentioned

GraphPad Prism
Excel

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.